?? Breaking News: URIT Medical has been accepted as a member of the International Council for Standardization in Hematology (ICSH)! This historic achievement places a Chinese IVD innovator at the heart of global hematology standard development.
?? ICSH Executive Officer Mr. Terry Fawcett recently visited URIT facilities, praising their "technical expertise, clinical problem-solving capabilities, and manufacturing quality control." ICSH sets the gold standard for hematology testing worldwide (https://www.icsh.org/about-us).
Why This Matters:
? Global Credibility Boost: URIT’s tech now carries ICSH’s authoritative endorsement – accelerating international market access.
? Bridging Standards Gap: Direct involvement in ICSH enables URIT to align Chinese IVD innovation with global traceability/quality frameworks.
? Expert Network Access: URIT will co-develop future standards alongside world-leading hematologists.
Spotlight on URIT’s Cutting-Edge Tech:
?? BS-8000 SERIES
MODULAR HEMATOLOGY WORKFLOW
? Up to 440 T/H
? Smart capillary blood testing
? CRP/SAA synergy for inflammation diagnostics
? Reliable cells microscope with slide maker and morphology module
?? BF-730
Flow Cytometer
? 3-laser, 14-color configuration
? No Beads Cost, innovative volumetric flow cytometry
? No consumable ceramic pump, cost-effective
?? BH-7000Vet
Compact 6-Diff Hematology Analyzer
? 21+ species profiles with 6-part WBC differentiation
? Nucleic dye tech for accurate immature cell detection
? The Takeaway:
"To walk with standard-setters is to own the future." URIT’s ICSH membership signals a new era where Chinese MedTech drives global precision healthcare innovation.
#Hematology #IVD #URIT #LaboratoryMedicine #ICSH #HealthInnovation